Myofascial Trigger Points
Conditions
Interventions
MICS Group: 20 women with myofascial trigger point (MTrPs) in the upper trapezius muscle
GJH Group: 20 women with MTrPs and general joint hypermobility
JHS Group: 20 women with MTrPs and joint hypermo
CID 10 M358
Sponsors
Universidade do Vale do Paraíba
Universidade do Vale do Paraíba
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Women with myofascial trigger point in the upper trapezius muscles; non history of cardiovascular disease (congenital or acquired in order); patients with general joint hypermobility in the Beighton’s criteria; patients with joint hypermobility syndrome in the Brighton’s criteria; women during the luteal phase of menstrual cycle.
Exclusion criteria
Exclusion criteria: Patients with central nervous system deficits; patients with cognitive deficits; patients receiving treatment by other methods like vapocoolants, dry needling, acupuncture injections etc; patients with myofascial trigger points in muscles other than muscle trapezius; history of cardiovascular disease (congenital or acquired), diabetes, respiratory disorders or metabolic diseases; users of hormonal medication; diagnosis of fibromyalgia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the modulation of sympathetic activity by the heart rate variability if the low-frequencies (0.04-0.15 Hz) are significantly after mics;To evaluate the pain modulation trough visual analog scale post mics protocol use | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate if MICS reduces pain muscle point. The reduces of pain intensity through visual analogue scale (VAS). A significance level of p value less than 0.05;To evaluate if MICS modulate the sympathetic activity in the low-frequencies and if they are significantly. A significance level of p value less than 0.05 | — |
Countries
Brazil
Contacts
Public ContactRodrigo Lazo-Osório
Outcome results
None listed